The relationship between IL6 and the kinetics of the ApoB-containing Lipoproteins in people with chronic inflammatory joint disease.
Phase of Trial: Phase IV
Latest Information Update: 17 Jun 2016
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- Acronyms apoB Kinetics; KALIBRA
- 12 Dec 2014 Planned End Date changed from 19 Apr 2015 to 11 Dec 2014 as reported by United Kingdom Clinical Research Network.
- 12 Dec 2014 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.
- 12 Nov 2014 Accrual to date is 80% according to United Kingdom Clinical Research Network